Definition
Ovarian cancer is a disease characterized
by the uncontrolled and disorganized proliferation of abnormal cells
on the surface of the ovary leading to the formation of a malignant
tumor. Cells in a malignant tumor have the capacity to spread to other
tissues and organs to form secondary tumors, called metastases.
Sources:
Ovarian Cancer. Microsoft
Encarta Encyclopedia 2000. Microsoft Corporation, 1999. http://www.encarta.msn.com
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
Frequency
in the Population
Ovarian cancer accounts for approximately
4% of all cancers affecting women. It is classified 5th
in terms of frequency and is the 5th leading cause of cancer
deaths among women. About 1 woman in 70 will develop ovarian cancer
during her lifetime, whereas 1 woman in 9 will develop breast cancer.
Approximately 15 new cases of ovarian cancer per 100 000 women are
diagnosed annually in industrialized countries.
Sources:
General Ovarian Cancer Statistics.
Ovarian Cancer National Alliance. U.S.A. http://www.ovariancancer.org
Le cancer de l'ovaire.
Fédération nationale des centres de lutte contre le cancer. France.
http://www.fnclcc.fr/indexcancer.htm
Ovarian Cancer. BC Cancer
Agency. Canada.
http://www.bccancer.bc.ca/cid/12.shtml#382
Ovarian Cancer in Canada -
October 1999. Current events on cancer. Health Canada. http://www.hc-sc.gc.ca/hpb/lcdc/bc/updates/ovar_e.html
What Every Woman Should Know
About Ovarian Cancer. National Ovarian Cancer Coalition. U.S.A.
http://www.ovarian.org
Ovarian
Cancer Survival Rate
The global survival rate for a
woman diagnosed with ovarian cancer is 35% to 47% after 5 years. If
the cancer is detected while it is confined to the ovary, the tumor
can easily be removed by surgery and 93% of patients will survive
at least 5 years. However, due to the fact that this cancer presents
few symptoms during its initial stages, only 24% of all cases are
detected early. For this reason, this cancer is often called "the
whispering cancer" or "the silent killer". When diagnosed in advanced
stages, the chance of 5-year survival is only about 25%.
Sources:
General Ovarian Cancer Statistics.
Ovarian Cancer National Alliance. U.S.A. http://www.ovariancancer.org
What Every Woman Should Know
About Ovarian Cancer. National Ovarian Cancer Coalition. U.S.A.
http://www.ovarian.org
Symptoms
- General abdominal discomfort
and/or pain (gas, indigestion, pressure, swelling, bloating, cramps)
- Feeling of fullness even after
a light meal
- Unexplained weight gain or loss
- Loss of appetite
- Nausea or vomiting, diarrhea,
constipation or frequent urination
- Sense of incomplete evacuation
of feces or narrowing of fecal caliber
- Lump in the abdomen, pelvis
or groin
- Back pain
- Difficulty in breathing, shortness
of breath
- Cough and/or discomfort in the
chest
- Swelling of the lower body
- Hormonal imbalance
- Low grade fever
- Painful intercourse
- Unusual fatigue
- Abnormal vaginal bleeding
Sources:
About Ovarian Cancer.
Ovarian Cancer Alliance Canada. http://www.ocac.ca
Ovarian Cancer. BC Cancer
Agency. Canada. http://www.bccancer.bc.ca/cid/12.shtml#382
Ovarian Cancer. Microsoft
Encarta Encyclopedia 2000. Microsoft Corporation, 1999. http://www.encarta.msn.com
What Every Woman Should Know
About Ovarian Cancer. National Ovarian Cancer Coalition. U.S.A.
http://www.ovarian.org
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
Risk
Factors and Prevention
The exact cause of ovarian cancer
is unknown; most cases are sporadic, occurring in women without any
apparent predisposition. However, certain studies indicate that the
following factors may increase or decrease the general 1.4% risk of
developing the disease.
Ovulatory history. The following
factors lead to a greater number of ovulations in a lifetime and moderately
increase the risk of developing ovarian cancer:
- Infertility
- Few or no full-term pregnancies
- First full-term pregnancy
after the age of 30
- Little or no breast-feeding
- Never used birth-control pills
- Hormonal stimulation of ovulation
(fertility drugs)
- First menstruation at an early
age and late menopause
Women who have had 3 or 4 full-term
pregnancies have about half the risk of women who have had none. Breast-feeding
also decreases the risk, and the longer the period of breast-feeding,
the lower the risk. Birth-control pills decrease the risk by 5% to
10% per year used. Taking the pill for 5 years therefore reduces the
risk by half. The protective effect seems to last at least 10 years
after the interruption of oral contraception.
Age. Most ovarian cancers
occur in women over the age of 50, with the highest risk in women
over 60.
Personal and family history.
Personal or family history of breast, ovarian, endometrial, prostate
or colon cancer increases the risk of developing ovarian cancer.
The general 1.4% probability of
being diagnosed with cancer increases to 7% if a first-degree relative
has ovarian cancer (mother, sister or daughter) and to 50% if 2 first-degree
relatives are diagnosed. In this case the cancer may appear before
the age of 50.
The presence of mutations in the
tumor suppressor genes BRCA-1 and BRCA-2 can increase the risk by
up to 40%. However, cancers of hereditary origin are infrequent and
constitute only 3 to 5% of ovarian cancers.
Removal of the ovaries.
Prophylactic oophorectomy is sometimes recommended for women with
a family history of ovarian cancer. While it significantly reduces
the risk of ovarian cancer, ovarian-like cancer is still possible.
Tubal ligation. This surgical
operation decreases the risk of developing ovarian cancer by 41%.
Hysterectomy. Removal of
the uterus may decrease the risk.
Nutrition. For every 10
g of saturated fat a woman consumes daily (about 1tablespoon), the
risk of developing ovarian cancer increases by 20%, while every 10
g of vegetal fiber consumed daily decrease the risk by 37%.
Exposure to talc or asbestos.
Industrial contamination, condoms dusted with talc, use of talc-based
powders in the genital area, may slightly increase the probability
of developing ovarian cancer. Cornstarch-based powders are a safe
alternative.
North American or North European
heritage and/or Ashkenazi Jewish population. Increased risk.
Living in an industrialized
country. Increased risk.
Sources:
Ovarian Cancer. BC Cancer
Agency. Canada. http://www.bccancer.bc.ca/cid/12.shtml#382
Ovarian Cancer Facts.
National Ovarian Cancer Association. Canada http://www.ovariancanada.org
Ovarian Cancer in Canada -
October 1999. Current events on cancer. Health Canada. http://www.hc-sc.gc.ca/hpb/lcdc/bc/updates/ovar_e.html
Ovarian Cancer. Microsoft
Encarta Encyclopedia 2000. Microsoft Corporation, 1999. http://www.encarta.msn.com
Risk Reduction. Ovarian
Cancer National Alliance. U.S.A. http://www.ovariancancer.org
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
Progression
of the Disease
- The Ovaries
The ovaries are almond-shaped glands
located in the pelvis on each side of the uterus. Each ovary contains
more than 100 000 ova, one of which is released each month at the
moment of ovulation. Fertilization of the ova by the sperm during
intercourse leads to pregnancy. At each ovulation, the ovarian follicle,
a fluid-filled sack containing the ova, breaks to release the ova.
The monthly cycle of rupture and healing, which results at the surface
of the ovary may be one of the causes of ovarian cancer.
The ovaries also secrete estrogens
and progesterone, female sex hormones that influence the development
of a woman's breasts, body shape and body hair, and that regulate
the menstrual cycle and pregnancy.
- Types of Cancers
Associated with the Ovary
Three types of cancers can develop
in the ovary:
Epithelial cancers. They
arise from the surface of the ovary are the most frequent and most
lethal cancers. Ovarian cancer is a cancer of this type.
Germ-cell cancers. They
arise from the ova and are very rare.
Stromal tumors. They arise
from the supportive tissues and are also very rare.
It should be noted that 80% of
tumors of the ovary are benign (i.e. that the abnormal cells do
not propagate to other tissues). This means that the presence of
a tumor implies a cancer in only 20% of all cases.
- Stages of
the Disease
Clinicians stage the cancer according
to its degree of confinement to the ovary or the extent of its spreading
in the body.
Stage I. The cancer is
limited to one or both ovaries.
Stage II. The cancer has
started to spread to the uterus or the fallopian tubes.
Stage III. The cancer
has spread outside the pelvis and secondary tumors have begun to
develop on the surface of various organs in the abdominal cavity.
Stage IV. Metastases have
formed outside the abdominal cavity, for example in the chest cavity.
- Grades of
the Disease
The disease is also classified
in terms of behavior of the cancerous cells (degree of organization
or differentiation and speed of growth):
Grade 1. The cells are
differentiated and usually do not spread.
Grade 2. The cells are
moderately differentiated. They can detach from the tumor and spread
to the pelvis and abdomen.
Grade 3. The cells are
undifferentiated. They are aggressive and tend to propagate quickly.
Sources:
A Guide to Ovarian Cancer
and its Treatment. Ovarian Cancer Alliance Canada. http://www.ocac.ca
Ovarian Cancer. BC Cancer
Agency. Canada. http://www.bccancer.bc.ca/cid/12.shtml#382
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
Detecting
and Diagnosing Ovarian Cancer
Pelvic exam.
Includes palpating the uterus, vagina, ovaries, fallopian tubes,
bladder and rectum to find any abnormality in size or shape.
Transvaginal
ultrasound. An image is created using high frequency sound
waves aimed at the ovaries with an apparatus placed in the vagina.
There is a difference between the images produced from the echo patterns
of tumors and healthy tissues.
Transvaginal
color flow doppler. Blood flow in the body is reproduced in
computerized images with color variations. The color pattern differs
according to whether blood flows through healthy or cancerous tissue.
CA-125 assay.
This blood test measures the level of CA-125, a glycoprotein that
is often found in greater quantities in the blood of women with ovarian
cancer.
X-rays.
The emission of x-rays through the body produces a two-dimensional
image of the internal structures of the body, highlighting abnormalities.
Computerized
axial tomography (CAT scan). The emission of x-rays following
a circle arc produces a very detailed transverse image of a section
of the body.
Biopsy.
A tissue sample is removed for examination under a microscope. To
reach the ovary, this procedure requires surgical incision of the
abdominal wall.
Analysis
of abdominal fluid samples. A sample of abdominal fluid taken
at the time of a biopsy can provide information about the nature of
the cells circulating there.
Laparotomy.
The abdomen is opened surgically for diagnosis, establishing the stage
of the disease, removing unhealthy tissue or taking tissue or fluid
samples.
Sources:
About Ovarian Cancer.
Ovarian Cancer Alliance Canada. http://www.ocac.ca
Ovarian Cancer. BC Cancer
Agency. Canada. http://www.bccancer.bc.ca/cid/12.shtml#382
Diagnosis. Ovarian Cancer
National Alliance. U.S.A. http://www.ovariancancer.org
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
What Every Woman Should Know
About Ovarian Cancer. National Ovarian Cancer Coalition. U.S.A.
http://www.ovarian.org
Women and Ovarian Cancer.
Current Oncology. Vol. 5, Supl. 2, Nov. 1998. http://www.multi-med.com/oncology
Treatment
of Ovarian Cancer
- Conventional
Therapies
Surgery. This treatment
is essential to remove all visible tumor. The surgeon must be careful
no to break or burst the tumor or tumors. Indeed, malignant cells
escaping back into the abdomen can cause the reappearance of cancer.
For this reason, other treatments must be added to the surgery, even
if only one tumor is visible.
Short-term side effects of surgery
include pain, discomfort, and tenderness in the area of the operation,
as well as difficulty with urination and bowel movements. Removal
of the ovaries causes the onset of menopause (hot flashes, vaginal
dryness, permanent termination of menstrual periods, etc.) and infertility.
Chemotherapy.
Chemotherapy uses drugs to kill cancer cells. The drugs
are administered in the form of pills or by injection and reach their
targets via the bloodstream. The chemical derivatives of platinum,
carboplatin and cisplatin, as well as taxol (paclitaxel) and topotecan
are common agents in the treatment of ovarian cancer.
The drugs also affect normal cells
and cause a variety of side effects. Nausea, vomiting, diarrhea, fatigue,
body aches, anemia, increased chance of bacterial infection, easily
bleeding, numbness and tingling in hands or feet, headaches, darkening
of the skin and fingernails, inflammation of the oral mucous membrane,
kidney damage, some hearing loss, hair loss and loss of appetite are
the main side effects associated with this approach.
Radiotherapy.
Radiotherapy uses high-energy radiation from x-rays, neutrons,
and other sources to kill cancer cells. The rays damage DNA, a molecule
that is repaired more easily by normal cells than by cancer cells.
Radiation can reach places inaccessible to surgery and causes less
damage because it can be administered very precisely.
Radiotherapy is not frequently
used for the treatment of ovarian cancer. It can cause fatigue, loss
of appetite, nausea, vomiting, urinary discomfort, diarrhea, skin
changes on the surface of the abdomen, abdominal pain and intestinal
blockage.
Sources:
A Guide to Ovarian Cancer
and its Treatment. Ovarian Cancer Alliance Canada. http://www.ocac.ca
Ovarian Cancer. BC Cancer
Agency. Canada. http://www.bccancer.bc.ca/cid/12.shtml#382
What You Need To Know About...
Ovarian Cancer. National Cancer Institute. U.S.A. NIH publication
No. 00-1561 U.S.A. http://www.cancernet.nci.nih.gov/wyntk_pubs/ovarian.htm#2
Women and Ovarian Cancer.
Current Oncology. Vol. 5, Supl. 2, Nov. 1998. http://www.multi-med.com/oncology
- Main Experimental
Approaches
Immunotherapy.
Immunological approaches aim at increasing the effectiveness
of the patient's immune system by increasing the number of lymphocytes
or antibodies directed against a tumor or by making cancer cells
more easily recognizable to the immune system.
Anti-angiogenesis.
Anti-angiogenesis aims at blocking the formation of new blood
vessels in the tumor to prevent the cancer cells from being nourished.
The tumor regresses due to a lack of the nutrients necessary for
its growth.
Senescence.
Molecules that act on the aging of the cells could be effective
for the treatment of cancers by triggering cell death. These molecules
inform the cells when an internal element necessary for their function
is defective. This event triggers the death of the cell through
a mechanism similar to that involved in leaves falling in autumn.
Gene therapy.
Gene therapy uses DNA. With this approach, a therapeutic gene is
integrated with the lymphocytes of the patient, the cancerous cells,
or with other accessory cells that will be used for the treatment.
Sources:
Ovarian Cancer Research
Notebook. National Ovarian Cancer Association. Canada. http://www.slip.net/~mcdavis/ovarian.html
Author: Liz Wirtanen, Ph.D.